Plain language summary of results from the DUO-E study: durvalumab given with or without olaparib in patients with advanced endometrial cancer

Shannon N. Westin, Kathleen Moore, Hye Sook Chon, Jung-Yun Lee, Jessica Thomes Pepin, Michael Sundborg, Ayelet Shai, Joseph de la Garza, Shin Nishio, Michael A. Gold, Ke Wang, Kristi McIntyre, Todd D. Tillmanns, Stephanie V. Blank, Ji-Hong Liu, Michael McCollum, Fernando Contreras Mejia, Tadaaki Nishikawa, Kathryn Pennington, Zoltan Novak, Andreia Cristina De Melo, Jalid Sehouli, Dagmara Klasa-Mazurkiewicz, Christos Papadimitriou, Marta Gil-Martin, Birute Brasiuniene, Conor Donnelly, Xiaochun Liu, Els Van Nieuwenhuysen, Unknown

Open source

DOI: 10.1080/14796694.2026.2638677
Published: 2026-04-06
Container: Future Oncology
Publisher: Informa UK Limited
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1080/14796694.2026.2638677,
  title = {Plain language summary of results from the DUO-E study: durvalumab given with or without olaparib in patients with advanced endometrial cancer},
  author = {Shannon N. Westin and Kathleen Moore and Hye Sook Chon and Jung-Yun Lee and Jessica Thomes Pepin and Michael Sundborg and Ayelet Shai and Joseph de la Garza and Shin Nishio and Michael A. Gold and Ke Wang and Kristi McIntyre and Todd D. Tillmanns and Stephanie V. Blank and Ji-Hong Liu and Michael McCollum and Fernando Contreras Mejia and Tadaaki Nishikawa and Kathryn Pennington and Zoltan Novak and Andreia Cristina De Melo and Jalid Sehouli and Dagmara Klasa-Mazurkiewicz and Christos Papadimitriou and Marta Gil-Martin and Birute Brasiuniene and Conor Donnelly and Xiaochun Liu and Els Van Nieuwenhuysen and Unknown},
  year = {2026},
  journal = {Future Oncology},
  doi = {10.1080/14796694.2026.2638677},
  url = {https://doi.org/10.1080/14796694.2026.2638677}
}

RIS

TY  - JOUR
TI  - Plain language summary of results from the DUO-E study: durvalumab given with or without olaparib in patients with advanced endometrial cancer
AU  - Shannon N. Westin
AU  - Kathleen Moore
AU  - Hye Sook Chon
AU  - Jung-Yun Lee
AU  - Jessica Thomes Pepin
AU  - Michael Sundborg
AU  - Ayelet Shai
AU  - Joseph de la Garza
AU  - Shin Nishio
AU  - Michael A. Gold
AU  - Ke Wang
AU  - Kristi McIntyre
AU  - Todd D. Tillmanns
AU  - Stephanie V. Blank
AU  - Ji-Hong Liu
AU  - Michael McCollum
AU  - Fernando Contreras Mejia
AU  - Tadaaki Nishikawa
AU  - Kathryn Pennington
AU  - Zoltan Novak
AU  - Andreia Cristina De Melo
AU  - Jalid Sehouli
AU  - Dagmara Klasa-Mazurkiewicz
AU  - Christos Papadimitriou
AU  - Marta Gil-Martin
AU  - Birute Brasiuniene
AU  - Conor Donnelly
AU  - Xiaochun Liu
AU  - Els Van Nieuwenhuysen
AU  - Unknown
PY  - 2026
JO  - Future Oncology
DO  - 10.1080/14796694.2026.2638677
UR  - https://doi.org/10.1080/14796694.2026.2638677
ER  -

APA

Westin, S. N., Moore, K., Chon, H. S., Lee, J., Pepin, J. T., Sundborg, M., Shai, A., Garza, J. D. L., Nishio, S., Gold, M. A., Wang, K., McIntyre, K., Tillmanns, T. D., Blank, S. V., Liu, J., McCollum, M., Mejia, F. C., Nishikawa, T., Pennington, K., Novak, Z., Melo, A. C. D., Sehouli, J., Klasa-Mazurkiewicz, D., Papadimitriou, C., Gil-Martin, M., Brasiuniene, B., Donnelly, C., Liu, X., Nieuwenhuysen, E. V., & Unknown (2026). Plain language summary of results from the DUO-E study: durvalumab given with or without olaparib in patients with advanced endometrial cancer. Future Oncology. https://doi.org/10.1080/14796694.2026.2638677

Source records

crossref · retrieved 2026-09-26T12:57:10.596Z